Skip to main content
. 2018 Jan 12;13:5. doi: 10.1186/s13019-018-0697-6

Table 1.

Patient characteristics

CT-guided percutaneous needle injection group Bronchoscopic injection group p Value
Study period Jan 2013 - Dec 2014 Jan 2015 - Dec 2016
Patients (n) 15 22
Age, years 61.5 ± 12.6 64.4 ± 10.0 N.S.
Sex Male 10 13 N.S.
Female 5 9
Tumour size (mm)
size range (mm)
10 ± 3.4
(4.0–17.1)
9.2 ± 3.6
(3.5–16.0)
N.S.
GGN (n)
Solid (n)
12
4
10
13
Depth from visceral pleura 9.9 ± 7.7 9.8 ± 8.1 N.S.
Localization
Right superior lobe
(S1, S2, S3)
7
(1, 4, 2)
6
(4, 1, 1)
Right middle lobe
(S4, S5)
Right inferior lobe
(S6, S7, S8, S9, S10)
Left superior lobe
(S1 + 2, S3, S4, S5)
Left inferior lobe
(S6, S8, S9, S10)
1
(0, 1)
4
(0, 0, 1, 2, 1)
3
(2, 1, 0, 0)
1
(0, 0, 1, 0)
1
(1, 0)
8
(0, 1, 2, 3, 2)
4
(3, 0, 1, 0)
4
(0, 1, 2, 1)

Data presented as median ± standard deviation; GGN: ground-glass nodule; Jan: January; Dec: December; S1: apical segment; S2: posterior segment; S3: anterior segment; right S4: lateral segment; right S5: medial segment; S6: superior segment; right S7: medial-basal segment; right S8: anterior-basal segment; S9: lateral segment; S10: posterior-basal segment; S1 + 2: apico-posterior segment; left S4: superior lingular segment; left S5: inferior lingular segment; left S8: anteriomedial basal segment; N.S.: not significant